Published in EJNMMI Res on December 09, 2015
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol (2016) 0.75
New perspectives in cell adhesion: RGD and integrins. Science (1987) 18.41
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev (1999) 12.52
Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2010) 11.16
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Senescence of activated stellate cells limits liver fibrosis. Cell (2008) 8.98
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol (2002) 8.21
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A (2009) 7.95
Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer (2002) 7.79
Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology (2005) 7.03
Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol (1987) 4.85
Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology (2008) 4.46
The integrins. Genome Biol (2007) 3.72
Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology (2008) 3.67
Integrin structure. Biochem Soc Trans (2000) 3.49
The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev (2004) 3.29
Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev (2004) 3.14
microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med (2005) 2.96
Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology (2009) 2.79
N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem (1999) 2.76
(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. J Nucl Med (2007) 2.50
Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology (1999) 2.45
Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (N Y) (1995) 2.45
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A (1991) 2.27
Molecular assembly, secretion, and matrix deposition of type VI collagen. J Cell Biol (1986) 2.07
T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology (2011) 2.05
Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol (2007) 2.02
Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett (1991) 2.02
Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology (2012) 1.93
Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest (1994) 1.91
Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem (2009) 1.88
Hepatic stellate cells and liver fibrosis. Compr Physiol (2013) 1.75
Acoustic radiation force impulse imaging of the abdomen: demonstration of feasibility and utility. Ultrasound Med Biol (2005) 1.73
A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science (1988) 1.68
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol (1996) 1.68
Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Anticancer Agents Med Chem (2006) 1.64
Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62
Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology (2008) 1.62
Elastography for the non-invasive assessment of liver disease: limitations and future developments. Gut (2009) 1.60
Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem (2004) 1.59
alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment. Curr Opin Cell Biol (2008) 1.57
Recruitment of vimentin to the cell surface by beta3 integrin and plectin mediates adhesion strength. J Cell Sci (2009) 1.48
Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J Biol Chem (1996) 1.44
Integrin targeted delivery of chemotherapeutics. Theranostics (2011) 1.42
Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. Mol Pharm (2009) 1.41
PET Imaging of Integrin αVβ3 Expression. Theranostics (2011) 1.41
Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). J Biol Chem (2008) 1.40
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol (2008) 1.38
Ligand interactions of the cation-independent mannose 6-phosphate receptor. The stoichiometry of mannose 6-phosphate binding. J Biol Chem (1989) 1.33
Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI. Exp Cell Res (1993) 1.33
The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II. J Biol Chem (1988) 1.24
99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study. J Nucl Med (2012) 1.23
SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J Immunol (2006) 1.21
Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology (2010) 1.18
Hepatic stellate cells: partners in crime for liver metastases? Hepatology (2011) 1.17
Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol (1996) 1.17
Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J Cell Biol (1990) 1.16
Tumor Targeting via Integrin Ligands. Front Oncol (2013) 1.15
Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy. Mol Ther (2011) 1.14
Multimodality Imaging of Integrin α(v)β(3) Expression. Theranostics (2011) 1.10
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells. Protein Eng Des Sel (2004) 1.08
Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology (1999) 1.08
MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication. Eur Radiol (2012) 1.05
Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. Mol Biol Cell (1993) 1.04
A synergistically enhanced T(1) -T(2) dual-modal contrast agent. Adv Mater (2012) 1.03
Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol (2011) 1.02
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol (2011) 1.02
Mannose 6-phosphate receptor targeting and its applications in human diseases. Curr Med Chem (2007) 1.01
Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor. J Biol Chem (2000) 1.01
Differential diagnosis of solitary pulmonary nodules using ⁹⁹mTc-3P₄-RGD₂ scintigraphy. Eur J Nucl Med Mol Imaging (2011) 1.01
Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem Biophys Res Commun (2005) 1.00
Evaluation of fibrotic liver disease with whole-liver T1ρ MR imaging: a feasibility study at 1.5 T. Radiology (2013) 1.00
Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin αvβ3-selective radiotracer 99mTc-3PRGD 2 in non-human primates. Mol Imaging Biol (2011) 0.99
Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation. EMBO J (1991) 0.98
Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma. J Hepatol (2014) 0.98
Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells. J Pharmacol Exp Ther (2007) 0.98
The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue. Biochem Pharmacol (2003) 0.96
Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces. Glycobiology (2010) 0.96
Correlation between Ito cells and fibrogenesis in an experimental model of hepatic fibrosis. A sequential stereological study. Liver (1983) 0.95
Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats. J Pharmacol Exp Ther (2007) 0.93
Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer. Mol Ther (2014) 0.89
Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers. J Pharmacol Exp Ther (2007) 0.88
Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J Viral Hepat (2008) 0.88
Radioimmunoassay for human type VI collagen and its application to tissue and body fluids. Anal Biochem (1985) 0.88
The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo. J Pharmacol Exp Ther (2006) 0.88
Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. Pharm Res (2007) 0.86
Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells. Pharm Res (2006) 0.86
Identification of a peptide antagonist for platelet-derived growth factor. J Biol Chem (1992) 0.86
Mono- and bivalent ligands bearing mannose 6-phosphate (M6P) surrogates: targeting the M6P/insulin-like growth factor II receptor. Org Lett (2004) 0.85
The lipocytes in normal human liver. A quantitative study. Digestion (1981) 0.85
Attachment of articular cartilage chondrocytes to the tissue form of type VI collagen. Biochim Biophys Acta (1995) 0.85
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front Pharmacol (2015) 0.85
Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis. J Control Release (2008) 0.84
Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin αvβ3 expression with SPECT in rat. Hepatology (2011) 0.84
The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells. Nanotechnology (2012) 0.83
Integrins and the kidney: biology and pathobiology. Curr Opin Nephrol Hypertens (1999) 0.82
Distribution and cellular origin of collagen VI during development and in cirrhosis. Gastroenterology (1992) 0.81
The efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals. Theranostics (2012) 0.81
MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide. Eur Radiol (2010) 0.81